|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 4, 182-190, Copyright © 1990 by European Association for Cardio-thoracic Surgery
TR Graham, K Dasse, A Coumbe, V Salih, MT Marrinan, OH Frazier and CT Lewis
Implantable left ventricular assist systems are being developed for long
term clinical use. Prototype devices are currently used as extended
mechanical bridges to cardiac transplantation. The Thermo Cardiosystems
Inc. (TCI) pneumatic pusher plate left ventricular assist device (LVAD)
features textured blood contacting surfaces to encourage the formation of
an adherent fibrin-cellular coagulum. This serves as the foundation for the
development of a neo-intimal lining. The TCI LVAD was implanted in 6 male
patients (age range 22-53 years) between 1986 and 1988. The duration of
implantation ranged from 1-41 days. No clinical thromboembolic events or
pump-related thromboembolism occurred and none was evident at necropsy. The
six device linings have been fully evaluated. Explanted devices were free
of thrombus and calcification. Lining samples for light and electron
microscopy were collected from areas of the diaphragm identical for flex
and blood shear conditions and from high and low shear areas on the static
housing. Islands of collagenous tissue were deposited on the static housing
amongst compact fibrin. By day 13, cells populated the surface of the
developing neo-intima overlying the diaphragm. By 41 days, the surface cell
density increased and the cells became spindle shaped and relatively
orientated in the high shear/flex area. Immunohistochemical techniques
suggest that these cells are of mesenchymal origin. Textured blood
contacting surfaces appear satisfactory in the preliminary clinical use of
this device.
ARTICLES
Neo-intimal development on textured biomaterial surfaces during clinical use of an implantable left ventricular assist device
London Hospital, UK.
This article has been cited by other articles:
![]() |
G. S. Kumpati, D. J. Cook, E. H. Blackstone, J. Rajeswaran, A. S. Abdo, J. B. Young, R. C. Starling, N. G. Smedira, and P. M. McCarthy HLA sensitization in ventricular assist device recipients: Does type of device make a difference? J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1800 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.W. Quinn, T.J.J. Jones, and T.R. Graham Mechanical Circulatory Support Sources of Emboli and Neurological Outcome Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 115 - 120. [Abstract] [PDF] |
||||
![]() |
D. Gagnon, M. Petty, and J. R Lahpor HeartMate(R) family of left ventricular assist systems Perfusion, July 1, 2000; 15(4): 345 - 354. [PDF] |
||||
![]() |
S. Christiansen, U. R. Jahn, J. Meyer, H. H. Scheld, H. Van Aken, B. E. Kehrel, and D. Hammel Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II Ann. Thorac. Surg., March 1, 2000; 69(3): 774 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Spanier, J. M. Chen, M. C. Oz, D. M. Stern, E. A. Rose, and A. M. Schmidt TIME-DEPENDENT CELLULAR POPULATION OF TEXTURED-SURFACE LEFT VENTRICULAR ASSIST DEVICES CONTRIBUTES TO THE DEVELOPMENT OF A BIPHASIC SYSTEMIC PROCOAGULANT RESPONSE J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 404 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baufreton, M. Kirsch, and D. Y. Loisance Measures to control blood activation during assisted circulation Ann. Thorac. Surg., November 1, 1998; 66(5): 1837 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Hunt and O.H. Frazier Mechanical Circulatory Support and Cardiac Transplantation Circulation, May 26, 1998; 97(20): 2079 - 2090. [Full Text] [PDF] |
||||
![]() |
O.H. Frazier The development, evolution, and clinical utilization of artificial heart technology Eur. J. Cardiothorac. Surg., April 1, 1997; 11(suppl): S29 - S31. [Abstract] [PDF] |
||||
![]() |
J. P. Slater, E. A. Rose, H. R. Levin, O. H. Frazier, J. K. Roberts, A. D. Weinberg, and M. C. Oz Low Thromboembolic Risk Without Anticoagulation Using Advanced-Design Left Ventricular Assist Devices Ann. Thorac. Surg., November 1, 1996; 62(5): 1321 - 1327. [Abstract] [Full Text] |
||||
![]() |
T. Spanier, M. Oz, H. Levin, A. Weinberg, K. Stamatis, D. Stern, E. Rose, and A. M. Schmidt ACTIVATION OF COAGULATION AND FIBRINOLYTIC PATHWAYS IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1090 - 1097. [Abstract] [Full Text] |
||||
![]() |
P. M. McCarthy, S. K. Schmitt, R. L. Vargo, S. Gordon, T. F. Keys, and R. E. Hobbs Implantable LVAD Infections: Implications for Permanent Use of the Device Ann. Thorac. Surg., January 1, 1996; 61(1): 359 - 365. [Abstract] [Full Text] |
||||
![]() |
S. Rafii, M. C. Oz, J. A. Seldomridge, B. Ferris, A. S. Asch, R. L. Nachman, F. Shapiro, E. A. Rose, and H. R. Levin Characterization of Hematopoietic Cells Arising on the Textured Surface of Left Ventricular Assist Devices Ann. Thorac. Surg., December 1, 1995; 60(6): 1627 - 1632. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |